Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03842891
Other study ID # CMUH106-REC1-115
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 25, 2017
Est. completion date September 25, 2018

Study information

Verified date February 2019
Source China Medical University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

DHA is important for the development of brain and retina in newborns. Considering that exclusive breast feeding for at least 4 ~6 months are globally recommended, plus it is well known that nutrient requirement is determined by both genetic and environmental (including diet) factors, this clinical study sought to investigate how the DHA levels in maternal milk is modulated by genetic variants and dietary n-3 LCPUFA intake. To recruit subjects (n=193), the inclusion criteria are Han Chinese women just having delivered full-term baby, 20-40 years old, healthy, and willing to breast feed their baby for at least 2 months. Written informed consent will be obtained from participants. Personal information (or covariates) such as height, weight (before getting pregnancy and delivery, respectively), age, parity, education, smoking, alcohol drinking, gender of baby…etc, and DNA from oral swab will be collected. Breast milk and dietary data will be collected at the end of the 1st and 2nd month of postpartum period. Considering Han Chinese women usually have special postpartum diets and care during puerperium, therefore, collection of breast milk and dietary information will be repeated at the 2nd month. The fatty acid composition in milk will be analyzed by gas chromatography. Using food frequency questionnaire, intake of n-3 LCPUFA from foods + fish oil supplements will be calculated. Subjects will be instructed to give a 3-days food record as well. We foresee results of this study might contribute to public health care as nutritionists/dietitians will be able to target the vulnerable subjects, who are dietary dependent for DHA, for dedications in nutrition consults or customized dietary guidance. Moreover, these information are valuable in making policy regarding dietary recommendation in Taiwan.


Recruitment information / eligibility

Status Completed
Enrollment 193
Est. completion date September 25, 2018
Est. primary completion date September 25, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Han Chinese women

- Full-term pregnancy(>36weeks)

- 20-40 years old

- Healthy

- Breast feed their baby for at least 2 months

Exclusion Criteria:

- Death before and after childbirth

- Child with congenital disease

Study Design


Locations

Country Name City State
Taiwan China Medical University Taichung

Sponsors (1)

Lead Sponsor Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Breast milk fatty acid composition Breast milk will be collected at the end of the 1st and 2nd month of postpartum period.The fatty acid composition in milk will be analyzed by gas chromatography. 2 month
See also
  Status Clinical Trial Phase
Completed NCT03799367 - The Feasibility of Drug Delivery to Infants During Breastfeeding N/A
Completed NCT03245697 - Breast Milk Composition: Interindividual Variations and Dietary Factors in Galicia
Recruiting NCT05979532 - A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk
Recruiting NCT04540575 - Reducing Disparity in Receipt of Mother's Own Milk in Very Low Birth Weight Infants N/A